Atlas Trials

LimmaTech Biologics AG

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch LimmaTech Biologics AG

RecordFirmDate
Safety and Immunogenicity Study of a Multivalent Gonorrhoea Vaccine (NCT07758972)LimmaTech Biologics AG2026-08-19
Study to Expand Safety and Immunogenicity Data With Shigella Bioconjugate Vaccine (Shigella4V2) in 9-month-old Infants. (NCT06523231)LimmaTech Biologics AG2025-04-07
A First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureus. (NCT06719219)LimmaTech Biologics AG2025-01-07
A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine (NCT06615375)LimmaTech Biologics AG2024-11-12
Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study (NCT06190509)LimmaTech Biologics AG2023-12-06
Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) (NCT04959344)LimmaTech Biologics AG2021-07-05
A Study to Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infants (NCT04056117)LimmaTech Biologics AG2019-09-02
Phase I to Test a New Pneumococcal Vaccine (NCT03303976)LimmaTech Biologics AG2017-09-07

Track LimmaTech Biologics AG automatically

Every clearance here is in the API, with alerts when new ones post.